000981 山子高科
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入707,908-32.62%3,268,4764,970,2055,335,8343,738,379
减:营业总成本823,519-27.90%3,826,6605,846,3306,558,7465,193,446
    其中:营业成本587,137-31.06%2,765,0094,156,6054,598,3643,451,505
               财务费用35,80932.55%51,182451,426394,089250,993
               资产减值损失(5,091)45.99%(542,073)(442,823)(378,974)(593,507)
公允价值变动收益0-100.00%192,15816,239(51,444)(49,466)
投资收益502,720189.28%2,512,390(564,572)(121,987)946,296
    其中:对联营企业和合营企业的投资收益(10,821)23.90%(50,964)(218,701)(184,998)(76,391)
营业利润384,353356.65%1,448,442(1,865,159)(1,882,254)(1,251,599)
利润总额384,206357.23%1,367,847(1,957,498)(1,901,900)(1,184,771)
减:所得税费用132,8951,182.94%386,813(153,285)317,447(67,084)
净利润251,311241.13%981,034(1,804,213)(2,219,347)(1,117,687)
减:非控股权益287-103.79%(44,744)(61,754)(162,599)(149,158)
股东净利润251,024208.94%1,025,778(1,742,460)(2,056,747)(968,529)

市场价值指针
每股收益 (元) *0.027228.40%0.110-0.170-0.210-0.100
每股派息 (元) *------------
每股净资产 (元) *0.310161.74%0.2860.1170.2920.459
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容